alexa Meningococcal Disease | Argentina | PDF | PPT| Case Reports | Symptoms | Treatment

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Conferences

Read more

Recommended Journals

Relevant Topics

Meningococcal Disease

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
  • Meningococcal Disease


    Meningococcal disease
    describes infections caused by the bacterium Neisseria meningitidis (also termed meningococcus). It carries a high mortality rate if untreated but is a vaccine-preventable disease.  Meningococci can also cause other problems, including a serious bloodstream infection called sepsis

  • Meningococcal Disease

    Disease pathophysiology:

    The disease's pathogenesis is not fully understood. The pathogen colonises a large number of the general population harmlessly, but in some very small percentage of individuals it can invade the blood stream, and the entire body but notably limbs and brain, causing serious illness. Over the past few years, experts have made an intensive effort to understand specific aspects of meningococcal biology and host interactions.

  • Meningococcal Disease

    Disease statistics:

    Meningitis is "silently" present, and there are always a few cases. When the number of cases passes five per population of 100,000 in one week, teams are on alert. Epidemic levels are reached when there have been 100 cases per 100,000 populations over several weeks. The meningococcal meningitis pandemic that began in 1996 has resulted so far in approximately 300,000 cases being reported

  • Meningococcal Disease

    Disease treatment:

    When meningococcal disease is suspected, treatment must be started immediately and should not be delayed while waiting for investigations. The antibiotics of choice are usually IV broad spectrum 3rd generation cephalosporins, e.g., cefotaxime or ceftriaxone. Benzylpenicillin and chloramphenicol are also effective. Supportive measures include IV fluids, oxygen, inotropic support, e.g., dopamine or dobutamine.

  • Meningococcal Disease

    Major research on disease:

    Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Steroid therapy may help in some adult patients, but is unlikely to affect long term outcomes.Genomic epidemiology of age-associated meningococcal lineages in national surveillance.

Expert PPTs

Speaker PPTs

 

High Impact List of Articles

Conference Proceedings

adwords